Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AGA Medical Amplatzer Trial For PFO To Start By Q3, Expanding On HDE

This article was originally published in The Gray Sheet

Executive Summary

AGA Medical plans to seek full PMA approval of its Amplatzer occluder system for patent foramen ovale (PFO) following receipt of limited approval via humanitarian device exemption, announced April 10

You may also be interested in...



AGA Medical Amplatzer Duct Occluder Is 97% Effective In Closing PDA

FDA approval of AGA Medical's Amplatzer Duct Occluder requires the firm to follow 435 study participants for five years post-implant, AGA says

AGA Medical Amplatzer Duct Occluder Is 97% Effective In Closing PDA

FDA approval of AGA Medical's Amplatzer Duct Occluder requires the firm to follow 435 study participants for five years post-implant, AGA says

FDA Taps Neurologists For NMT Medical’s PFO Closure Device, First To Panel

NMT Medical's PMA filing for its StarFlex implant for the closure of patent foramen ovale will be the first device to be reviewed for that indication by FDA's Circulatory System Devices Panel, the company notes

Related Content

UsernamePublicRestriction

Register

MT016397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel